Antitumor and other effects of 24R,25-dihydroxycholecalciferol in Lewis lung carcinoma causing abnormal calcium metabolism in tumor-bearing mice. 1988

Y Maeda, and H Yamato, and T Hirai, and N Kobori, and T Fujii, and Y Kobayashi, and K Saitoh, and E Inoguchi, and M Hakozaki, and H Iijima
Biomedical Research Laboratories, Kureha Chemical Industry Co., Ltd., Tokyo, Japan.

Lewis lung carcinoma was found to cause hypercalcemia in tumor-bearing mice. 24R,25(OH)2D3 (K-DR, prepared by Kureha Chemical Ind.) significantly prolonged the survival time of mice with Lewis lung carcinoma. K-DR exhibited an antimetastatic effect on Lewis lung carcinoma, and also had an analgesic effect in mice with Lewis lung carcinoma.

UI MeSH Term Description Entries
D008175 Lung Neoplasms Tumors or cancer of the LUNG. Cancer of Lung,Lung Cancer,Pulmonary Cancer,Pulmonary Neoplasms,Cancer of the Lung,Neoplasms, Lung,Neoplasms, Pulmonary,Cancer, Lung,Cancer, Pulmonary,Cancers, Lung,Cancers, Pulmonary,Lung Cancers,Lung Neoplasm,Neoplasm, Lung,Neoplasm, Pulmonary,Pulmonary Cancers,Pulmonary Neoplasm
D008297 Male Males
D008810 Mice, Inbred C57BL One of the first INBRED MOUSE STRAINS to be sequenced. This strain is commonly used as genetic background for transgenic mouse models. Refractory to many tumors, this strain is also preferred model for studying role of genetic variations in development of diseases. Mice, C57BL,Mouse, C57BL,Mouse, Inbred C57BL,C57BL Mice,C57BL Mice, Inbred,C57BL Mouse,C57BL Mouse, Inbred,Inbred C57BL Mice,Inbred C57BL Mouse
D008813 Mice, Inbred ICR An inbred strain of mouse that is used as a general purpose research strain, for therapeutic drug testing, and for the genetic analysis of CARCINOGEN-induced COLON CANCER. Mice, Inbred ICRC,Mice, ICR,Mouse, ICR,Mouse, Inbred ICR,Mouse, Inbred ICRC,ICR Mice,ICR Mice, Inbred,ICR Mouse,ICR Mouse, Inbred,ICRC Mice, Inbred,ICRC Mouse, Inbred,Inbred ICR Mice,Inbred ICR Mouse,Inbred ICRC Mice,Inbred ICRC Mouse
D009362 Neoplasm Metastasis The transfer of a neoplasm from one organ or part of the body to another remote from the primary site. Metastase,Metastasis,Metastases, Neoplasm,Metastasis, Neoplasm,Neoplasm Metastases,Metastases
D002118 Calcium A basic element found in nearly all tissues. It is a member of the alkaline earth family of metals with the atomic symbol Ca, atomic number 20, and atomic weight 40. Calcium is the most abundant mineral in the body and combines with phosphorus to form calcium phosphate in the bones and teeth. It is essential for the normal functioning of nerves and muscles and plays a role in blood coagulation (as factor IV) and in many enzymatic processes. Coagulation Factor IV,Factor IV,Blood Coagulation Factor IV,Calcium-40,Calcium 40,Factor IV, Coagulation
D002277 Carcinoma A malignant neoplasm made up of epithelial cells tending to infiltrate the surrounding tissues and give rise to metastases. It is a histological type of neoplasm and not a synonym for "cancer." Carcinoma, Anaplastic,Carcinoma, Spindle-Cell,Carcinoma, Undifferentiated,Carcinomatosis,Epithelial Neoplasms, Malignant,Epithelioma,Epithelial Tumors, Malignant,Malignant Epithelial Neoplasms,Neoplasms, Malignant Epithelial,Anaplastic Carcinoma,Anaplastic Carcinomas,Carcinoma, Spindle Cell,Carcinomas,Carcinomatoses,Epithelial Neoplasm, Malignant,Epithelial Tumor, Malignant,Epitheliomas,Malignant Epithelial Neoplasm,Malignant Epithelial Tumor,Malignant Epithelial Tumors,Neoplasm, Malignant Epithelial,Spindle-Cell Carcinoma,Spindle-Cell Carcinomas,Tumor, Malignant Epithelial,Undifferentiated Carcinoma,Undifferentiated Carcinomas
D004100 Dihydroxycholecalciferols Cholecalciferols substituted with two hydroxy groups in any position. Dihydroxyvitamins D
D006934 Hypercalcemia Abnormally high level of calcium in the blood. Milk-Alkali Syndrome,Hypercalcemias,Milk Alkali Syndrome,Syndrome, Milk-Alkali
D000700 Analgesics Compounds capable of relieving pain without the loss of CONSCIOUSNESS. Analgesic,Anodynes,Antinociceptive Agents,Analgesic Agents,Analgesic Drugs,Agents, Analgesic,Agents, Antinociceptive,Drugs, Analgesic

Related Publications

Y Maeda, and H Yamato, and T Hirai, and N Kobori, and T Fujii, and Y Kobayashi, and K Saitoh, and E Inoguchi, and M Hakozaki, and H Iijima
January 1980, Pharmacological research communications,
Y Maeda, and H Yamato, and T Hirai, and N Kobori, and T Fujii, and Y Kobayashi, and K Saitoh, and E Inoguchi, and M Hakozaki, and H Iijima
March 1987, Hiroshima journal of medical sciences,
Y Maeda, and H Yamato, and T Hirai, and N Kobori, and T Fujii, and Y Kobayashi, and K Saitoh, and E Inoguchi, and M Hakozaki, and H Iijima
January 1992, Pharmacological research,
Y Maeda, and H Yamato, and T Hirai, and N Kobori, and T Fujii, and Y Kobayashi, and K Saitoh, and E Inoguchi, and M Hakozaki, and H Iijima
November 1991, Japanese journal of cancer research : Gann,
Y Maeda, and H Yamato, and T Hirai, and N Kobori, and T Fujii, and Y Kobayashi, and K Saitoh, and E Inoguchi, and M Hakozaki, and H Iijima
November 1989, European journal of cancer & clinical oncology,
Y Maeda, and H Yamato, and T Hirai, and N Kobori, and T Fujii, and Y Kobayashi, and K Saitoh, and E Inoguchi, and M Hakozaki, and H Iijima
January 1980, Methods in enzymology,
Y Maeda, and H Yamato, and T Hirai, and N Kobori, and T Fujii, and Y Kobayashi, and K Saitoh, and E Inoguchi, and M Hakozaki, and H Iijima
June 2006, International immunopharmacology,
Y Maeda, and H Yamato, and T Hirai, and N Kobori, and T Fujii, and Y Kobayashi, and K Saitoh, and E Inoguchi, and M Hakozaki, and H Iijima
September 1984, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.),
Y Maeda, and H Yamato, and T Hirai, and N Kobori, and T Fujii, and Y Kobayashi, and K Saitoh, and E Inoguchi, and M Hakozaki, and H Iijima
January 1977, Cancer research,
Y Maeda, and H Yamato, and T Hirai, and N Kobori, and T Fujii, and Y Kobayashi, and K Saitoh, and E Inoguchi, and M Hakozaki, and H Iijima
June 1984, Gan to kagaku ryoho. Cancer & chemotherapy,
Copied contents to your clipboard!